A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases
- Camilla Thellenberg-Karlsson
- , Egils Vjaters
- , Marju Kase
- , Teuvo Tammela
- , Kristiina Ojamaa
- , Ulf Norming
- , Claes Nyman
- , Sven Olof Andersson
- , Oleg Hublarovs
- , Marcela Marquez-Holmberg
- , Enrique Castellanos
- , Anders Ullen
- , Anders Holmberg
- , Sten Nilsson (Corresponding Author)
Research output: Contribution to journal › Article › peer-review
6
Citations
(Scopus)
14
Downloads
(Pure)